157 related articles for article (PubMed ID: 10423051)
21. Early deaths in children after BMT. Bone Marrow Transplantation Group of the Italian Association for Pediatric Hematology and Oncology (AIEOP) and Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Garaventa A; Porta F; Rondelli R; Dini G; Meloni G; Bonetti F; Uderzo C; De Manzini A; Miniero R; Brutti F
Bone Marrow Transplant; 1992 Nov; 10(5):419-23. PubMed ID: 1464003
[TBL] [Abstract][Full Text] [Related]
22. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
[TBL] [Abstract][Full Text] [Related]
23. Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey.
Engelhard D; Cordonnier C; Shaw PJ; Parkalli T; Guenther C; Martino R; Dekker AW; Prentice HG; Gustavsson A; Nurnberger W; Ljungman P;
Br J Haematol; 2002 May; 117(2):444-50. PubMed ID: 11972532
[TBL] [Abstract][Full Text] [Related]
24. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients.
Jantunen E; Ruutu P; Niskanen L; Volin L; Parkkali T; Koukila-Kähkölä P; Ruutu T
Bone Marrow Transplant; 1997 Apr; 19(8):801-8. PubMed ID: 9134172
[TBL] [Abstract][Full Text] [Related]
25. Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children.
Kaya Z; Weiner DJ; Yilmaz D; Rowan J; Goyal RK
Biol Blood Marrow Transplant; 2009 Jul; 15(7):817-26. PubMed ID: 19539213
[TBL] [Abstract][Full Text] [Related]
26. Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation.
Lenssen P; Bruemmer BA; Bowden RA; Gooley T; Aker SN; Mattson D
Am J Clin Nutr; 1998 May; 67(5):927-33. PubMed ID: 9583851
[TBL] [Abstract][Full Text] [Related]
27. Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation.
Nagler A; Aker M; Or R; Naparstek E; Varadi G; Brautbar C; Slavin S
Exp Hematol; 2001 Mar; 29(3):362-70. PubMed ID: 11274765
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologic malignancies: a single-center experience.
Bacigalupo A; Zikos P; Van Lint MT; Valbonesi M; Lamparelli T; Gualandi F; Occhini D; Mordini N; Bregante S; Berisso G; Vitale V; Sessarego M; Marmont AM
Exp Hematol; 1998 May; 26(5):409-14. PubMed ID: 9590657
[TBL] [Abstract][Full Text] [Related]
29. Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.
Vasconcelles MJ; Bernardo MV; King C; Weller EA; Antin JH
Biol Blood Marrow Transplant; 2000; 6(1):35-43. PubMed ID: 10707997
[TBL] [Abstract][Full Text] [Related]
30. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
[TBL] [Abstract][Full Text] [Related]
31. Impact of stem cell source on allogeneic stem cell transplantation outcome in hematological malignancies.
Stamatović D; Balint B; Tukić L; Elez M; Tarabar O; Todorović M; Ostojić G; Tatomirovic Z; Ljubenov M; Marjanović S; Malesević M
Vojnosanit Pregl; 2011 Dec; 68(12):1026-32. PubMed ID: 22352263
[TBL] [Abstract][Full Text] [Related]
32. Cytomegalovirus infection in recipients of related and unrelated donor bone marrow transplants: no evidence of increased incidence in patients receiving unrelated donor grafts.
Foot AB; Pamphilon D; Caul EO; Roome AP; Hunt LP; Cornish JM; Oakhill A
Br J Haematol; 1998 Aug; 102(3):671-7. PubMed ID: 9722292
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus infection after pediatric bone marrow transplantation.
Hale GA; Heslop HE; Krance RA; Brenner MA; Jayawardene D; Srivastava DK; Patrick CC
Bone Marrow Transplant; 1999 Feb; 23(3):277-82. PubMed ID: 10084260
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate vs Cyclosporin A as a single agent for graft-versus-host disease prophylaxis in pediatric patients with hematological malignancies undergoing allogeneic bone marrow transplantation from HLA-identical siblings: a single-center analysis in Japan.
Koga Y; Nagatoshi Y; Kawano Y; Okamura J
Bone Marrow Transplant; 2003 Jul; 32(2):171-6. PubMed ID: 12838282
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary complications and respiratory function changes after bone marrow transplantation in children.
Fanfulla F; Locatelli F; Zoia MC; Giorgiani G; Bonetti F; Spagnolatti L; Cerveri I
Eur Respir J; 1997 Oct; 10(10):2301-6. PubMed ID: 9387957
[TBL] [Abstract][Full Text] [Related]
36. A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group.
List AF; Maziarz R; Stiff P; Jansen J; Liesveld J; Andrews F; Schuster M; Wolff S; Litzow M; Karanes C; Dahlberg S; Kirkhart B; Bianco JA; Singer JW
Bone Marrow Transplant; 2000 Feb; 25(3):283-91. PubMed ID: 10673700
[TBL] [Abstract][Full Text] [Related]
37. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
Solano C; Martinez C; Brunet S; Tomás JF; Urbano-Ispizua A; Zuazu J; Ojeda E; Bargay J; Moraleda JM; Bailen A; Sierra J; García-Conde J; Rozman C
Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714
[TBL] [Abstract][Full Text] [Related]
38. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies.
Ruescher TJ; Sodeifi A; Scrivani SJ; Kaban LB; Sonis ST
Cancer; 1998 Jun; 82(11):2275-81. PubMed ID: 9610710
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
[TBL] [Abstract][Full Text] [Related]
40. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
